Versant Capital Management »

Neurogene shares owned by Versant Capital Management

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $571 33 17.33
2025-06-30 $493 33 14.94

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Microsoft Stock (MSFT)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Ishares S&p Global Energy Etf (IXC)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Nvidia Corp Stock (NVDA)
Apple Stock (AAPL)
Vanguard Total Stk Mkt Etf (VTI)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Dimensional Us Marketwide Value Etf Etf (DFUV)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)

View all positions for Versant Capital Management

Top funds holding Neurogene

Samsara BioCapital
Rtw Investments
Redmile Group
Casdin Capital
EcoR1 Capital
Baker Bros. Advisors
BlackRock
Balyasny Asset Management
Toronto-Dominion Bank
Vanguard Group
Arrowpoint Asset Management
Morgan Stanley
Dr. Jeffrey R. Jay, M.D.
Jennison Associates
Octagon Capital Advisors

View all funds holding Neurogene